Shuanglian Li

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

Johnny Mahlangu, Jerry S. Powell, Margaret V. Ragni et al. · Blood · 2013 · 441 citations · Full text

Medicine, Hematology, Molecular Biology +14

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Jerry S. Powell, John Pasi, Margaret V. Ragni et al. · New England Journal of Medicine · 2013 · 352 citations · Full text

Medicine, Hematology, Immunology +14

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin

Ying Chen, Shuanglian Li, Chaline Brown et al. · Pharmacogenetics and Genomics · 2009 · 243 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

Ligong Chen, Yan Shu, Xiaomin Liang et al. · Proceedings of the National Academy of Sciences · 2014 · 237 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non–Small Cell Lung Cancer with <i>EGFR</i> Exon 20 Insertion Mutations from a Phase I/II Trial

Gregory J. Riely, Joel W. Neal, D. Ross Camidge et al. · Cancer Discovery · 2021 · 222 citations · Full text

Medicine, Oncology, Pharmacology +16